SAN FRANCISCO, May 30, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will be presenting data from six studies at the 2017 American College of Veterinary Internal Medicine (ACVIM) conference in National Harbor, MD, held June 8-10, 2017. The Company will be sharing effectiveness and safety data from its Mirataz™ (mirtazapine transdermal ointment) and Zimeta™ (dipyrone injection) development programs and sponsoring scientific sessions. In addition, KindredBio will be sponsoring five Scientific Sessions at the conference.
“We are proud that all six of the abstracts we submitted to the ACVIM conference have been accepted. We are particularly excited to share the detailed effectiveness and safety data for both Mirataz and Zimeta. Additionally, we are pleased to be sponsoring scientific content presented by highly respected veterinary thought-leaders,” stated Richard Chin, M.D., CEO of KindredBio.
Mirataz Posters:
- Safety of Mirtazapine Transdermal Ointment Administered Topically to Cats at 5 mg/kg for 28 Days (P10)
- Double-Blind, Placebo-Controlled, Randomized Study of Mirtazapine Transdermal Ointment for the Management of Feline Weight Loss (P11)
- Single Dose Pharmacokinetics Following Transdermal Application and Oral Administration of Mirtazapine Ointment in Cats (P12)
- Multiple Dose Pharmacokinetics of Mirtazapine Transdermal Ointment in Cats (P13)
Zimeta Posters:
- A Randomized, Blinded, Placebo-Controlled, Crossover Study of Dipyrone to Control Fever in Horses (P54)
- A Placebo-Controlled Study of the Clinical Safety of an Oral Formulation of Dipyrone in Horses (P55)
KindredBio-Sponsored Scientific Sessions:
- Thursday, June 8th, 11:30 AM – 12:20 PM ET
Nutritional Management of Equine Gastric Ulcers: What Do We Really Know?
Frank Andrews, DVM, MS, DACVIM - Friday, June 9th, 6:30 – 8:00 AM ET
Strategies for Management of Weight Loss and Cachexia in Cats
Jessica Quimby, DVM, PhD, DACVIM - Friday, June 9th, 2:10 – 3:00 PM ET
Ataxia is Not the Only Clinical Manifestation of Neck Injuries
Jean Marie Denoix, DVM, PhD, ISELP Certified Instructor - Friday, June 9th, 3:10 – 4:00 PM ET
Diagnosis of Low Back (Lumbar and Lumbosacral) Pain in Equine Athletes
Jean Marie Denoix, DVM, PhD, ISELP Certified Instructor - Saturday, June 10th, 10:00 – 10:50 AM ET
The Old Horse: Medical Management with a Focus on PPID and Insulin Dysregulation
Harold Schott, DVM, PhD, DACVIM
Elizabeth Tadros, DVM
The Company will also be holding discussions with veterinarians interested in KindredBio’s pipeline at Booth #100 in the Exhibit Hall during ACVIM.
About Kindred Biosciences
Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company’s strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.